Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Graham

Showing results (951-960 of 994) with videos related to

Pageof 100
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 26, 2013
Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitorsJohn S Debenham, Thomas H Graham, Andreas Verras, et al.
Rhinology|April 13, 2021
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNPM Desrosiers, L P Mannent, N Amin, et al.
Journal of the American Academy of Dermatology|June 24, 2020
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trialAmy S Paller, Elaine C Siegfried, Diamant Thaçi, et al.
Cell Reports|March 1, 2016
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast CancerJun Hyoung Park, Sajna Vithayathil, Santosh Kumar, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2012
A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluationThomas H Graham, Wensheng Liu, Andreas Verras, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 28, 2019
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic RhinosinusitisJorge F Maspero, Constance H Katelaris, William W Busse, et al.
Applied and Environmental Microbiology|May 27, 2026
Mars sample return campaign: biological risk and a proposed sample safety assessment protocolG McDonnell, B L Teece, R Mackelprang, et al.
Lancet (London, England)|August 7, 2022
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 studyBoon H Chua, Emma K Link, Ian H Kunkler, et al.
The New England Journal of Medicine|May 22, 2018
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled AsthmaMario Castro, Jonathan Corren, Ian D Pavord, et al.
Neuron|December 27, 2016
Loss of Nardilysin, a Mitochondrial Co-chaperone for α-Ketoglutarate Dehydrogenase, Promotes mTORC1 Activation and NeurodegenerationWan Hee Yoon, Hector Sandoval, Sonal Nagarkar-Jaiswal, et al.
Pageof 100

Showing results (951-960 of 994) with videos related to

Sort By:
Pageof 100
Bioorganic & Medicinal Chemistry Letters|October 26, 2013
Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitorsJohn S Debenham, Thomas H Graham, Andreas Verras, et al.
Rhinology|April 13, 2021
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNPM Desrosiers, L P Mannent, N Amin, et al.
Journal of the American Academy of Dermatology|June 24, 2020
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trialAmy S Paller, Elaine C Siegfried, Diamant Thaçi, et al.
Cell Reports|March 1, 2016
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast CancerJun Hyoung Park, Sajna Vithayathil, Santosh Kumar, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2012
A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluationThomas H Graham, Wensheng Liu, Andreas Verras, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 28, 2019
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic RhinosinusitisJorge F Maspero, Constance H Katelaris, William W Busse, et al.
Applied and Environmental Microbiology|May 27, 2026
Mars sample return campaign: biological risk and a proposed sample safety assessment protocolG McDonnell, B L Teece, R Mackelprang, et al.
Lancet (London, England)|August 7, 2022
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 studyBoon H Chua, Emma K Link, Ian H Kunkler, et al.
The New England Journal of Medicine|May 22, 2018
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled AsthmaMario Castro, Jonathan Corren, Ian D Pavord, et al.
Neuron|December 27, 2016
Loss of Nardilysin, a Mitochondrial Co-chaperone for α-Ketoglutarate Dehydrogenase, Promotes mTORC1 Activation and NeurodegenerationWan Hee Yoon, Hector Sandoval, Sonal Nagarkar-Jaiswal, et al.
Pageof 100